EPISODE · Mar 24, 2019 · 45 MIN

Ketamine

from The Psychiatrists Guide · host Rafael Coira, MD, JD and James Sherer, MD

Rafael Coira, MD, JD and James Sherer, MD discuss the new FDA approval of the Esketamine nasal spray for treatment of depression. Marketed under the trade name Spravato, Esketamine promises to reverse depression in one day, but what are the risks of taking a medication derived from the drug PCP?

Episode metadata supplied by the publisher feed · Published Mar 24, 2019

Embed this episode

Attribution link and audio player

Ready to play

Ketamine

0:00 45:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Psychiatrists Guide?

This episode is 45 minutes long.

When was this The Psychiatrists Guide episode published?

This episode was published on March 24, 2019.

Can I download this The Psychiatrists Guide episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!